PHC Holdings Corporation (TYO:6523)
Japan · Delayed Price · Currency is JPY 1,053.00
-37.00 (-3.39%)
Sep 10, 2025, 3:30 PM JST
PHC Holdings Revenue
PHC Holdings had revenue of 83.86B JPY in the quarter ending June 30, 2025, a decrease of -1.56%. This brings the company's revenue in the last twelve months to 360.26B, up 0.70% year-over-year. In the fiscal year ending March 31, 2025, PHC Holdings had annual revenue of 361.59B with 2.17% growth.
Revenue (ttm)
360.26B
Revenue Growth
+0.70%
P/S Ratio
0.37
Revenue / Employee
39.85M
Employees
9,041
Market Cap
133.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 361.59B | 7.69B | 2.17% |
| Mar 31, 2024 | 353.90B | -2.53B | -0.71% |
| Mar 31, 2023 | 356.43B | 15.98B | 4.69% |
| Mar 31, 2022 | 340.45B | 34.38B | 11.23% |
| Mar 31, 2021 | 306.07B | 33.43B | 12.26% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |